Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-23T12:50:42.455Z Has data issue: false hasContentIssue false

Relation Between Long Term Antipsychotic Treatment and Osteoporosis

Published online by Cambridge University Press:  15 April 2020

A. Rady
Affiliation:
Psychiatry, Alexandria University School of Medicine, Alexandria, Egypt
A. Elsheshai
Affiliation:
Psychiatry, Alexandria University School of Medicine, Alexandria, Egypt
M. Elsheikh
Affiliation:
Radiology, Alexandria University School of Medicine, Alexandria, Egypt
M. Eltawel
Affiliation:
Psychiatry, Al Mamoura Psychiatric Hospital, Alexandria, Egypt

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and Aim of Work

Osteoporosis and frequent fractures are reported in schizophrenic patients, Hyperprolactinemia can be contributing to bone demineralization. Since antipsychotics are themselves the commonest iatrogenic etiology to hyperprolactinemia, long term antipsychotic use may be contributing to osteopenia

Subjects and Methods

30 schizophrenic patients with chronic course receiving antipsychotic for 2-10 years compared to 20 drug naïf schizophrenic patients. Patients on cortisol therapy, debilitating chronic illness or suffering from rheumatic disorders were excluded. Bone density evaluated by Dual energy X ray absorbtiometry and serum level; of prolactine measured

Results

Among schizophrenic patients on medication, 40% were on respiridone, 10% on clozapine, 33.3% on haloperidol and 16.7% on olanzapine.significant difference showed up between schizophrenic patient on medication and drug naïf as regards bone miniral density T score (X2 = 3.25; p< 0.05)

Conclusion

Osteopenia is common among schizophrenic patients receiving prolactine raising antipsychotics, raising the urge to screen for bone density among those with long term use of psychotropes

Type
Article: 1729
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.